A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet (M) Mutations on Tigecycline Resistance
Restricted accessResearch articleFirst published online June, 2020
A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet (M) Mutations on Tigecycline Resistance
Tigecycline-resistant enterococci are only rarely detected worldwide. In 2017, the National Reference Centre for Staphylococci and Enterococci noticed a nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium (TVRE) in a hospital of tertiary care in Northern Germany. Nineteen E. faecium isolates were analyzed by means of antimicrobial susceptibility testing and pulsed-field gel electrophoresis. A subset of isolates was subjected to whole-genome sequencing. The genetic basis of tigecycline resistance was assessed by ResFinder and by comparative analyses to known tetracycline and tigecycline resistance genes. Phylogenetic investigations revealed the clustering of 11 TVRE that exhibited genotype ST117/CT1489. Two tigecycline-susceptible isolates were unrelated. Characterization of the genetic determinant putatively responsible for tigecycline resistance revealed two chromosomal changes in the TVRE population: (1) a deletion within the ribosomal protein gene rpsJ and (2) a serine insertion in and removal of transcriptional regulation of the ribosomal protection protein Tet(M). We here report the first nosocomial cluster of TVRE in a German hospital and disclosed the resistance mechanism that was most likely causative for tigecycline insusceptibility. Clonal spread of TVRE isolates can be assumed because all isolates were highly related and harbored identical chromosomal alterations associated with tigecycline resistance.
Get full access to this article
View all access options for this article.
References
1.
LeongK.W.C., CooleyL.A, AndersonT.L, GautamS.S, McEwanB., WellsA., WilsonF., HughsonL., and O'TooleR.F. 2018. Emergence of vancomycin-resistant Enterococcus faecium at an Australian hospital: a whole genome sequencing analysis. Sci. Rep. 8:6274.
2.
PfallerM.A., CormicanM., FlammR.K, MendesR.E, and JonesR.N.. 2019. Temporal and geographic variation in antimicrobial susceptibility and resistance patterns of Enterococci: results from the SENTRY antimicrobial surveillance program, 1997–2016. Open Forum. Infect. Dis. 6:S54–S62.
3.
SteinG.E., and BabinchakT.. 2013. Tigecycline: an update. Diagn. Microbiol. Infect. Dis. 75:331–336.
4.
JennerL., StarostaA.L, TerryD.S, MikolajkaA., FilonavaL., YusupovM., BlanchardS.C, WilsonD.N, and YusupovaG.. 2013. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc. Natl. Acad. Sci. U. S. A. 110:3812–3816.
5.
GrossmanT.H.2016. Tetracycline antibiotics and resistance. Cold Spring Harb. Perspect. Med. 6:a025387.
6.
ThakerM., SpanogiannopoulosP., and WrightG.D.. 2010. The tetracycline resistome. Cell. Mol. Life Sci. 67:419–431.
7.
CordinaC., HillR., DeshpandeA., HoodJ., and InksterT.. 2012. Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J. Antimicrob. Chemother. 67:1806–1807.
8.
FiedlerS., BenderJ.K, KlareI., HalbedelS., GrohmannE., SzewzykU., and WernerG.. 2016. Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M). J. Antimicrob. Chemother. 71:871–881.
9.
NiebelM., QuickJ., PrietoA.M, HillR.L, PikeR., HuberD., DavidM., HornseyM., WarehamD., OppenheimB., WoodfordN., van SchaikW., and LomanN.. 2015. Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. Int. J. Antimicrob. Agents. 46:572–575.
10.
WernerG., GfrorerS., FleigeC., WitteW., and KlareI.. 2008. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J. Antimicrob. Chemother. 61:1182–1183.
11.
BeaboutK., HammerstromT.G, PerezA.M, MagalhaesB.F, PraterA.G, ClementsT.P, AriasC.A, SaxerG., and ShamooY.. 2015. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob. Agents Chemother. 59:5561–5566.
12.
BeaboutK., HammerstromT.G, WangT.T, BhattyM., ChristieP.J, SaxerG., and ShamooY.. 2015. Rampant parasexuality evolves in a hospital pathogen during antibiotic selection. Mol. Biol. Evol. 32:2585–2597.
13.
CattoirV., IsnardC., CosquerT., OdhiamboA., BucquetF., GuerinF., and GiardJ.C.. 2015. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium. Antimicrob. Agents Chemother. 59:239–244.
14.
DabulA.N.G., Avaca-CruscaJ.S, NavaisR.B, MerloT.P, Van TyneD., GilmoreM.S, and CamargoI.. 2019. Molecular basis for the emergence of a new hospital endemic tigecycline-resistant Enterococcus faecalis ST103 lineage. Infect. Genet. Evol. 67:23–32.
15.
McAleeseF., PetersenP., RuzinA., DunmanP.M, MurphyE., ProjanS.J, and BradfordP.A.. 2005. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob. Agents Chemother. 49:1865–1871.
16.
ForsbergK.J., PatelS., WencewiczT.A, and DantasG.. 2015. The tetracycline destructases: a novel family of tetracycline-inactivating enzymes. Chem. Biol. 22:888–897.
HassanR.M., GhaithD.M, IsmailD.K, and ZaferM.M.. 2018. Reduced susceptibility of Enterococcus spp. isolates from Cairo University Hospital to tigecycline: highlight on the influence of proton pump inhibitors. J. Glob. Antimicrob. Resist. 12:68–72.
19.
KreskenM., Korber-IrrgangB., PetrikC., SeifertH., RodloffA., and BeckerK.. 2016. Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006–2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST). GMS Infect. Dis. 4:Doc07.
20.
WernerG., KlareI., FleigeC., and WitteW.. 2008. Increasing rates of vancomycin resistance among Enterococcus faecium isolated from German hospitals between 2004 and 2006 are due to wide clonal dissemination of vancomycin-resistant enterococci and horizontal spread of vanA clusters. Int. J. Med. Microbiol. 298:515–527.
21.
ChopraI., and RobertsM.. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232–260; second page, table of contents.
22.
SuY.A., HeP., and ClewellD.B.. 1992. Characterization of the tet(M) determinant of Tn916: evidence for regulation by transcription attenuation. Antimicrob. Agents Chemother. 36:769–778.
23.
NeelyA.N., and MaleyM.P.. 2000. Survival of Enterococci and Staphylococci on hospital fabrics and plastic. J. Clin. Microbiol. 38:724–726.
24.
WeberD.J., AndersonD., and RutalaW.A.. 2013. The role of the surface environment in healthcare-associated infections. Curr. Opin. Infect. Dis. 26:338–344.
25.
LinkeviciusM., SandegrenL., and AnderssonD.I.. 2016. Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob. Agents Chemother. 60:789–796.
26.
DonhoferA., FranckenbergS., WicklesS., BerninghausenO., BeckmannR., and WilsonD.N.. 2012. Structural basis for TetM-mediated tetracycline resistance. Proc. Natl. Acad. Sci. U. S. A. 109:16900–16905.
